Cas:23462-25-1 Phenazine-1,6-dicarboxylic acid manufacturer & supplier

We serve Chemical Name:Phenazine-1,6-dicarboxylic acid CAS:23462-25-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Phenazine-1,6-dicarboxylic acid

Chemical Name:Phenazine-1,6-dicarboxylic acid
CAS.NO:23462-25-1
Synonyms:1,6-Phenazinedicarboxylic acid
Molecular Formula:C14H8N2O4
Molecular Weight:268.22400
HS Code:2933990090

Physical and Chemical Properties:
Melting point:325ºC; 333ºC(分解)(正辛醇)
Boiling point:628.4ºC at 760mmHg
Density:1.585g/cm3
Index of Refraction:1.794
PSA:100.38000
Exact Mass:268.04800
LogP:2.17940

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 1,6-Phenazinedicarboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1,6-Phenazinedicarboxylic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,6-Phenazinedicarboxylic acid Use and application,1,6-Phenazinedicarboxylic acid technical grade,usp/ep/jp grade.


Related News: At the same time, experts said that API companies need to increase investment in environmental protection, carry out industrial upgrades, improve processes, improve pollution treatment capabilities, and then achieve sustainable development in the future, and seize structural opportunities. Phenazine-1,6-dicarboxylic acid manufacturer No amount of unmet need can take the place of sufficient evidence, said Johns Hopkins public health professor Dr. Caleb Alexander, a member of the FDA advisory panel. Phenazine-1,6-dicarboxylic acid supplier This decision has shaken the foundations of the scientific process and methods, said Dr. Jason Karlawish, co-director of the Penn Memory Center in Philadelphia. Karlawish ran one of the trial sites for the Biogen drug. Phenazine-1,6-dicarboxylic acid vendor At the same time, experts said that API companies need to increase investment in environmental protection, carry out industrial upgrades, improve processes, improve pollution treatment capabilities, and then achieve sustainable development in the future, and seize structural opportunities. Phenazine-1,6-dicarboxylic acid factory This decision has shaken the foundations of the scientific process and methods, said Dr. Jason Karlawish, co-director of the Penn Memory Center in Philadelphia. Karlawish ran one of the trial sites for the Biogen drug.